| TITLE |
DATE |
| Quidel Receives CE Mark for Its Sofia(TM) Strep A Fluorescent Immunoassay (FIA) Test |
1-Dec-2011 |
| Quidel to Present at 23rd Annual Piper Jaffray Health Care Conference |
18-Nov-2011 |
| Quidel to Present at Credit Suisse 2011 Health Care Conference |
2-Nov-2011 |
| Quidel Receives 510(k) Clearance of Its Sofia(TM) Fluorescent Immunoassay Analyzer and Influenza A+B FIA Test |
26-Oct-2011 |
| Quidel Reports Third Quarter 2011 Financial Results |
25-Oct-2011 |
| Quidel to Hold Third Quarter 2011 Financial Results Conference Call on October 25, 2011 |
4-Oct-2011 |
| Quidel Receives CE Mark for Its Molecular Diagnostic Test for Human Metapneumovirus (hMPV) |
21-Sep-2011 |
| Quidel Receives CE Mark for Its Sofia Fluorescent Immunoassay Analyzer and Influenza A+B FIA Test |
16-Aug-2011 |
| Quidel Receives CE Mark for Its First Molecular Diagnostic Test |
5-Aug-2011 |
| Quidel Reports Second Quarter 2011 Financial Results |
2-Aug-2011 |
| Quidel to Hold Second Quarter 2011 Financial Results Conference Call on August 2, 2011 |
19-Jul-2011 |
| Quidel to Present at Bank of America Merrill Lynch Health Care Conference |
5-May-2011 |
| Quidel Reports First Quarter 2011 Financial Results |
28-Apr-2011 |
| Quidel to Hold First Quarter 2011 Financial Results Conference Call on April 28, 2011 |
15-Apr-2011 |
| Quidel to Host 2011 Analyst Day in Boston |
1-Apr-2011 |
| Quidel to Present at Citi 2011 Global Health Care Conference |
25-Feb-2011 |
| Quidel Reports Fourth Quarter and Full Year 2010 Results |
24-Feb-2011 |
| Quidel to Hold Fourth Quarter and Full Year 2010 Results Conference Call on February 24, 2011 |
4-Feb-2011 |
| Quidel to Present at JP Morgan 29th Annual Healthcare Conference |
7-Jan-2011 |
| Quidel Announces Pricing of Common Shares Offering |
6-Jan-2011 |
| Quidel Announces Proposed Common Shares Offering |
5-Jan-2011 |
| Quidel Reports Third Quarter 2010 Results |
27-Oct-2010 |
| Quidel to Hold Third Quarter 2010 Results Conference Call on October
27, 2010 |
13-Oct-2010 |
| Quidel Announces FDA Clearance of Its QuickVue(R) RSV 10 Immunoassay Diagnostic Test |
29-Sep-2010 |
| Quidel Announces FDA Clearance of Its RapidVue(R) hCG Pregnancy Lateral Flow Diagnostic Test |
31-Aug-2010 |
| Quidel to Present at Canaccord Genuity 30th Annual Growth Conference |
4-Aug-2010 |
| Quidel to Present at Wedbush Life Sciences Best Ideas Management Access Conference |
30-Jul-2010 |
| Quidel Reports Second Quarter 2010 Results |
29-Jul-2010 |
| Quidel Announces the Availability of Its QuickVue(R)+Infectious Mononucleosis Lateral Flow Diagnostic Test |
26-Jul-2010 |
| Quidel to Hold Second Quarter 2010 Results Conference Call on July 29, 2010 |
9-Jul-2010 |
| Diagnostic Hybrids Receives Approval from Chinese SFDA for D3(R)Ultra(TM) DFA Respiratory Virus Screening and ID Kit |
1-Jul-2010 |
| Quidel Reports First Quarter 2010 Results |
29-Apr-2010 |
| Quidel to Hold First Quarter 2010 Results Conference Call on April
29, 2010 |
15-Apr-2010 |
| Diagnostic Hybrids Receives FDA Emergency Use Authorization for D3 Ultra 2009 H1N1 Influenza A Virus ID Kit |
23-Feb-2010 |
| Quidel Corporation Completes Acquisition of Diagnostic Hybrids |
19-Feb-2010 |
| Quidel Reports Fourth Quarter and Full Year 2009 Results |
11-Feb-2010 |
| Quidel to Hold Fourth Quarter and Full Year 2009 Results Conference Call on February 11, 2010 |
29-Jan-2010 |
| Quidel Corporation Announces Definitive Agreement to Acquire Diagnostic Hybrids |
10-Jan-2010 |
| Quidel Corporation to Present at the 28th Annual J.P. Morgan Healthcare Conference |
4-Jan-2010 |
| Quidel Authorizes Additional $25 Million under Stock Repurchase Program |
8-Dec-2009 |
| Quidel Reports Third Quarter 2009 Results |
16-Oct-2009 |
| Quidel Announces Launch of Their MicroVue(R) C5a EIA Kit for Research Use Only |
16-Oct-2009 |
| Quidel Corporation Announces Joint Development and Commercialization Agreement with BioHelix Corporation |
6-Oct-2009 |
| Quidel to Present at the William Blair & Company Emerging Growth Stock Conference |
22-Sep-2009 |
| Quidel Issues Clarification Regarding Special 510(k) Clearance to Add 2009 H1N1 Influenza A Virus Reactivity Information to the QuickVue Influenza A+B Test Package Insert |
18-Sep-2009 |
| Quidel Obtains Special 510(k) Clearance to Add 2009 H1N1 Influenza A Virus Reactivity Information to the QuickVue Influenza A+B Test Package Insert |
17-Sep-2009 |
| Quidel Anticipates Record Quarterly Results Driven by Strong Demand for Flu Tests |
10-Sep-2009 |
| Quidel to Present at Investor Conferences in September |
10-Sep-2009 |
| Quidel Launches Flu Test Educational Programs for the Clinical Community |
10-Aug-2009 |
| Quidel Announces Executive Appointments |
6-Aug-2009 |
| Quidel Reports Second Quarter 2009 Results |
22-Jul-2009 |
| Quidel to Hold 2009 Second Quarter Conference Call on July 22, 2009 |
9-Jul-2009 |
| Quidel Corporation to Attend the Sixth Annual Craig-Hallum Institutional Investor Conference |
10-Jun-2009 |
| Quidel Reports First Quarter 2009 Results |
22-Apr-2009 |
| Quidel to Hold 2009 First Quarter Conference Call on April 22, 2009 |
8-Apr-2009 |
| Quidel Announces Strategic Restructuring and Work Force Reduction |
31-Mar-2009 |
| Quidel Provides Update on Impact of Current Influenza Season and Macroeconomic Trends |
16-Mar-2009 |
| Quidel Schedules Conference Call for March 16, 2009 to Provide Business Update |
13-Mar-2009 |
| Quidel Reports Fourth Quarter and Full Year 2008 Results |
25-Feb-2009 |
| Quidel Corporation Webinar Addresses Management of Influenza in Long-Term Care Facilities |
18-Feb-2009 |
| Quidel to Hold 2008 Fourth Quarter and Year-End Financial Results Conference Call on February 25, 2009 |
10-Feb-2009 |
| Quidel Corporation Appoints Douglas C. Bryant President & Chief Executive Officer |
20-Jan-2009 |
| Quidel Launches rsvtesting.com; Web Site Delivers Practical Information on Respiratory Syncytial Virus (RSV) |
19-Jan-2009 |
| Quidel Corporation to Present at the 27th Annual J.P. Morgan Healthcare Conference |
6-Jan-2009 |
| Caren L. Mason, President & CEO, to Retire from Quidel in 2009 |
5-Jan-2009 |
| Quidel's QuickVue(R) iFOB Test Results Show High Correlation with Quantitative Laboratory Assay for Fecal Occult Blood Using Stools from Patients with Post-Colonoscopy Based Clinical Diagnosis |
9-Dec-2008 |
| Quidel Authorizes Additional $25 Million under Stock Repurchase Program |
2-Dec-2008 |
| Quidel to Present at the 20th Annual Piper Jaffray Healthcare Conference |
1-Dec-2008 |
| Quidel Announces Promotion of John Tamerius, Ph.D. to Senior Vice President, Clinical/Regulatory Affairs |
7-Nov-2008 |
| Quidel Reports Third Quarter 2008 Results |
22-Oct-2008 |
| Quidel Corporation Secures New $120 Million Credit Facility |
9-Oct-2008 |
| Quidel to Hold 2008 Third Quarter Conference Call on October 22, 2008 |
8-Oct-2008 |
| Quidel Influenza Test Selected for FluSTAR(R) Surveillance Program |
22-Sep-2008 |
| Quidel to Present at the UBS 2008 Global Life Sciences Conference |
16-Sep-2008 |
| CORRECTING and REPLACING Quidel Reports Second Quarter 2008 Results |
23-Jul-2008 |
| Quidel Reports Second Quarter 2008 Results |
23-Jul-2008 |
| Quidel to Hold 2008 Second Quarter Conference Call on July 23, 2008 |
9-Jul-2008 |
| Quidel and Prodesse Announce Flu and RSV Molecular Partnership |
20-May-2008 |
| Quidel Reports First Quarter 2008 Results |
23-Apr-2008 |
| Quidel to Hold 2008 First Quarter Conference Call on April 23, 2008 |
9-Apr-2008 |
| Quidel Corporation and Susie's Cause Partner in Colorectal Cancer Awareness Event |
4-Mar-2008 |
| FDA Grants CLIA Waiver for Quidel's QuickVue(R) RSV Test |
29-Feb-2008 |
| Quidel Reports Fourth Quarter and Full Year 2007 Results |
21-Feb-2008 |
| Quidel to Hold 2007 Fourth Quarter and Year-End Financial Results Conference Call on February 21, 2008 |
11-Feb-2008 |
| Quidel and bioMerieux Announce a Global Strategic Alliance in Rapid Diagnostics |
15-Jan-2008 |
| Quidel Corporation and Roche to Collaborate in Pilot Program for Influenza Management in U.S. This Flu Season |
6-Dec-2007 |
| Dr. Kenneth F. Buechler Appointed to Quidel Corporation Board of Directors |
6-Nov-2007 |
| Quidel Reports Strong Third Quarter Results |
24-Oct-2007 |
| Quidel to Hold 2007 Third Quarter Financial Results Conference Call on October 24 |
17-Oct-2007 |
| Adventist Health System, Largest Not-for-Profit Health System in the U.S., Selects Quidel as Flu Test Supplier |
16-Oct-2007 |
| Physicians More Appropriately Prescribe Treatment after Rapid Flu and RSV Testing of Pediatric Patients |
8-Oct-2007 |
| Use of Quidel QuickVue(R) Rapid Flu Test in Nursing Homes Allows for More Rapid Recognition of Outbreaks and Appropriate Therapies |
8-Oct-2007 |
| Exclusive Agreement Announced Between Quidel Corporation and Roche Pharma AG |
26-Sep-2007 |
| Quidel to Present at the UBS 2007 Global Life Sciences Conference |
19-Sep-2007 |
| Quidel Reports Strong Second Quarter Results |
26-Jul-2007 |
| Quidel Corporation Announces Exclusive Licenses to Molecular Antiviral Resistance and Detection Technology for Influenza |
17-Jul-2007 |
| Quidel to Hold 2007 Second Quarter Financial Results Conference Call on July 26 |
16-Jul-2007 |
| Quidel Announces Promotion of Scot M. McLeod to Senior Vice President, Operations |
26-Jun-2007 |
| Quidel Announces Appointment of Industry Veteran Richard C. Tarbox III as Senior Vice President, Corporate Development Officer |
26-Jun-2007 |
| Quidel Announces Mark E. Paiz Resignation |
1-Jun-2007 |
| Quidel to Present at the Bank of America 2007 Health Care Conference |
30-May-2007 |
| Quidel Reports Strong First Quarter Results with Revenues up 25%, Operating Income up 49%, Diluted EPS of $0.14 |
26-Apr-2007 |
| Quidel to Hold 2007 First Quarter Financial Results Conference Call on April 26 |
19-Apr-2007 |
| LabCorp Adopts Quidel Corporation's QuickVue(R) iFOB Test |
27-Mar-2007 |
| Quidel Authorizes Additional $25 Million under Stock Repurchase Program |
12-Mar-2007 |
| Quidel Corporation and Cholestech Corporation Partner to Offer ''Derm Kit'' to Help Dermatologists Achieve iPLEDGE(TM) Compliance |
22-Feb-2007 |
| Quidel Corporation and Scripps Hospital Partner in Colorectal Cancer Awareness Event |
21-Feb-2007 |
| Quidel Announces Strong Fourth Quarter and Full Year Results for 2006 |
15-Feb-2007 |
| Quidel to Hold 2006 Fourth Quarter and Year-End Financial Results Conference Call on February 15 |
7-Feb-2007 |
| Quidel Names John M. Radak Chief Financial Officer |
3-Jan-2007 |
| Quidel Announces Worldwide, Exclusive License for Novel DNA Microarray (MChip) for Global Influenza Surveillance |
19-Dec-2006 |
| Quidel to Present at BIO Drug/Device Summit 2006 on December 4 |
29-Nov-2006 |
| Quidel to Present at BIOCOM San Diego Investor Conference on November 15 |
8-Nov-2006 |
| Quidel Announces Third Quarter Results |
1-Nov-2006 |
| Quidel to Hold 2006 Third Quarter Financial Results Conference Call on November 1 |
18-Oct-2006 |
| Quidel to Present at UBS Global Life Sciences on September 27 |
20-Sep-2006 |
| Quidel Announces FDA 510(k) Clearance of Their New Rapid Test for Detection of Respiratory Syncytial Virus (RSV); RSV Causes Approximately 100,000 Hospitalizations in the U.S. Each Year(1) |
18-Sep-2006 |
| Quidel Announces CFO Retirement Effective March 31, 2007 |
7-Sep-2006 |
| Quidel Announces Second Quarter Results; Worldwide Product Sales up 21% |
2-Aug-2006 |
| Quidel to Hold 2006 Second Quarter Financial Results Conference Call on August 2 |
19-Jul-2006 |
| Quidel to Present at Pacific Growth Equities 2006 Life Sciences Growth Conference on June 13 |
6-Jun-2006 |
| Quidel Announces Record First Quarter Results with Worldwide Product Sales up 24%, Diluted EPS of $0.15 |
26-Apr-2006 |
| Quidel to Hold 2006 First Quarter Financial Results Conference Call on April 26 |
19-Apr-2006 |
| Quidel Corporation Announces Strategic Business Partnership with Church & Dwight Co., Inc. |
16-Mar-2006 |
| Quidel Expands Influenza Testing in European Community; German School System and French Soccer Team Adopt the QuickVue(R) Influenza A+B Test |
21-Feb-2006 |
| Quidel Announces Strong Fourth Quarter Results; Reports Earnings from Continuing Operations of $0.28 Per Share |
15-Feb-2006 |
| Quidel Corporation Appoints Jack W. Schuler and Rod F. Dammeyer to Its Board of Directors |
7-Feb-2006 |
| Quidel to Hold 2005 Fourth Quarter and Year-End Financial Results Conference Call on February 15 |
1-Feb-2006 |
| Quidel Corporation Appoints Renowned Leaders in the Diagnosis and Treatment of Infectious Disease to Medical Advisory Board |
20-Jan-2006 |
| Quidel Corporation Elaborates upon Flu Test Claims, Including Data for All Specimen Types |
6-Jan-2006 |
| Quidel's Flu Test Receives FDA Clearance for New Claims; Company Projects Strong Finish for 2005 |
29-Dec-2005 |
| Quidel Announces Third Quarter Financial Results; Total Revenues up 47%; Worldwide Product Sales up 58% |
26-Oct-2005 |
| Quidel to Hold Third Quarter 2005 Financial Results Conference Call on October 26 |
12-Oct-2005 |
| Quidel Announces Strategic Business Partnerships at ASBMR Conference; Specialty Products Group Expands Global Capabilities in Osteoporosis Products |
26-Sep-2005 |
| Quidel Joins Fight for Early Detection of Colon Cancer; Expands Product Portfolio to Target 50 Million U.S. Test Market for Fecal Occult Blood Tests |
15-Sep-2005 |
| Study Validates Sensitivity of Quidel Rapid Test to Detect Bacterial Vaginosis; Condition Accounts for over 10 Million Physician Office Visits in the U.S. Annually |
12-Aug-2005 |
| Quidel Corporation Appoints Renowned Experts in Reproductive Health to Advisory Board; Erudite Panel Rounds out Company's Clinical Expertise |
1-Aug-2005 |
| Quidel Reports Second Quarter Financial Results |
27-Jul-2005 |
| Quidel to Hold Second Quarter 2005 Financial Results Conference Call on July 27 |
14-Jul-2005 |
| Quidel Announces Stock Repurchase Program |
14-Jun-2005 |
| Quidel to Present at Pacific Growth Equities Life Sciences Growth Conference on June 7 |
26-May-2005 |
| Study Validates Higher Sensitivity of Quidel's QuickVue Influenza A+B Test among Rapid Flu Tests; University of Rochester Presents Research at Clinical Virology Symposium |
10-May-2005 |
| Quidel Reports First Quarter Financial Results; Conference Call to Begin at 2:00 p.m. PT/5:00 p.m. ET Today |
10-May-2005 |
| Quidel to Hold First Quarter 2005 Financial Results Conference Call on May 10 |
4-May-2005 |
| Inverness Medical Innovations and Quidel Announce Settlement of Intellectual Property Litigation |
27-Apr-2005 |
| Quidel Reports Settlement of Inverness Litigation and 17% Increase in Total Revenues for First Quarter |
27-Apr-2005 |
| Quidel to Hold First Quarter 2005 Financial Results Conference Call on April 27 |
12-Apr-2005 |
| Quidel Reports Strong Fourth Quarter Results |
16-Feb-2005 |
| Quidel Fourth Quarter and 2004 Financial Results Conference Call Alert |
2-Feb-2005 |
| Quidel Names Thomas D. Brown to Board of Directors; Addition of Veteran Abbott Laboratories Executive Expands Board to Seven |
13-Dec-2004 |
| Quidel Corporation Receives 2004 ``Best in Class'' Award from HPIS; Award Recognizes Highest Year-to-Date Growth in the Immunology Reagents/Supplies Category |
6-Dec-2004 |
| Quidel Affirms Confidence in Patent Litigation |
22-Nov-2004 |
| Quidel Names Thomas J. Foley Chief Technology Officer |
1-Nov-2004 |
| Quidel Reports Third Quarter Financial Results |
27-Oct-2004 |
| Quidel Launches flutest.com; Interactive Web Site Delivers Practical Flu Solutions For Consumers |
21-Oct-2004 |
| Quidel Third Quarter 2004 Results Conference Call Alert |
14-Oct-2004 |
| Quidel Names Caren L. Mason Chief Executive Officer; Former GE General Manager Women's Healthcare Brings To Quidel Strong Customer and Operating Skills |
23-Aug-2004 |
| Quidel Reports Second Quarter Financial Results |
28-Jul-2004 |
| Quidel Second Quarter 2004 Results Conference Call Alert |
14-Jul-2004 |
| Quidel Corporation Announces Departure of S. Wayne Kay, President and CEO; Mark E. Paiz Promoted to Chief Operating Officer |
13-Jul-2004 |
| Quidel Expects Second Quarter Total Revenues of $14.3 Million and Estimates Net Loss of $0.12 Per Share; Quidel Suspends 2004 Financial Guidance |
9-Jul-2004 |
| Quidel to Present at Pacific Growth Equities Life Sciences Growth Conference on June 10 at 1:30 p.m. Pacific Time |
7-Jun-2004 |
| Quidel Board Elects Mark A. Pulido Chairman |
2-Jun-2004 |
| Quidel Reports First Quarter Financial Results |
28-Apr-2004 |
| Quidel First Quarter 2004 Results Conference Call Alert |
14-Apr-2004 |
| Quidel Expects First Quarter Total Revenues of $19.7 Million and Estimates EPS of $0.01; Results Reflect Softness in U.S. and Japan Markets for Influenza and Strep A Tests |
7-Apr-2004 |
| Quidel to Present at the S.G. Cowen 24th Annual Health Care Conference on March 10, 2004 at 11:15 a.m. EST |
8-Mar-2004 |
| Quidel Revises 2004 EPS Guidance Due to Expected Litigation Expenses for Previously Announced Patent Lawsuits |
27-Feb-2004 |
| FDA Grants CLIA-Waived Status to Quidel's QuickVue Influenza A+B Test |
25-Feb-2004 |
| Quidel Files Patent Infringement Lawsuit against Inverness Medical Innovations and Advises of Other New Litigation |
23-Feb-2004 |
| Quidel Reports Record Fourth Quarter Financial Results; Company Raises 2004 Financial Guidance; Chairman Andre de Bruin Announces Retirement |
11-Feb-2004 |
| Quidel Fourth Quarter and Full-Year 2003 Results Conference Call Alert |
28-Jan-2004 |
| Quidel Reports Third Quarter Revenue and Margin Gains; Restructuring Largely Completed, Early Indications of Strong Influenza Season |
29-Oct-2003 |
| Quidel Third Quarter 2003 Conference Call Alert |
15-Oct-2003 |
| Quidel Signs Distributor Agreements in Germany and Italy |
17-Sep-2003 |
| Quidel Bolsters Management Team with the Addition of Global Sales and Marketing Senior Vice President |
15-Sep-2003 |
| Quidel Expands Distribution of QuickVue Strep A Test to Physician Sales and Service |
8-Sep-2003 |
| Quidel Reports Second Quarter Revenue and Margin Gains; Company Confirms 2003 and 2004 Guidance |
30-Jul-2003 |
| Quidel Second Quarter 2003 Conference Call Alert |
10-Jul-2003 |
| Quidel Executives Invited by HHS Secretary Thompson and FDA Commissioner McClellan to Participate in Meeting on Developing Diagnostic Tests for SARS |
3-Jun-2003 |
| Quidel Reports Strong First Quarter Revenues; Revises 2003 Guidance Upward and Introduces 2004 Guidance; Restructuring Initiative Undertaken to Drive Shareholder Value |
29-Apr-2003 |
| Quidel First Quarter 2003 Conference Call Alert |
11-Apr-2003 |
| Quidel QuickVue Influenza Test Offers 10-Minute Test Results to Evaluate Respiratory Symptoms |
2-Apr-2003 |
| Quidel Streamlines Structure of Executive Team |
27-Mar-2003 |
| Quidel to Present at the S.G. Cowen 23rd Annual Health Care Conference on March 19, 2003 at 10:00 A.M. EST |
17-Mar-2003 |
| Quidel Reports Fourth Quarter Pre-Tax EPS of $0.07, Revenues of $22.8 Million |
10-Feb-2003 |
| Quidel to Present at The Wall Street Analyst Forum on February 12, 2003 at 9:00 a.m. EST |
29-Jan-2003 |
| Quidel Fourth Quarter Conference Call Alert |
27-Jan-2003 |
| Quidel Introduces 2003 Financial Guidance |
17-Dec-2002 |
| Quidel Corporation to Present at CCBN Virtual Healthcare Conference |
6-Dec-2002 |
| Quidel 2003 Financial Guidance Conference Call Alert |
3-Dec-2002 |
| Quidel Announces Urinalysis Automated Analyzer Now Available Worldwide |
20-Nov-2002 |
| Quidel Announces Worldwide Commercialization of its Layered Thin Film™ Products |
20-Nov-2002 |
| Quidel Reports Third Quarter Financial Results |
30-Oct-2002 |
| Quidel Appoints Donald J. Lovre as Corporate Accounts Manager |
9-Oct-2002 |
| Quidel Third Quarter Conference Call Alert |
8-Oct-2002 |
| Quidel Updates Third Quarter Financial Guidance |
3-Oct-2002 |
| Corporate Profile for Quidel Corporation, dated Sept. 27, 2002 |
27-Sep-2002 |
| Quidel Corporation's QuickVue(R) Dipstick Strep A Test Receives Governmental Approval in Japan |
17-Sep-2002 |
| Quidel to Present at Wells Fargo Securities' Class of 2002 Conference |
29-Aug-2002 |
| Quidel Receives Additional Patent Protection On Layered Thin Film Technology |
29-Aug-2002 |
| Quidel Names Mark A. Pulido to Its Board of Directors; Adds Impressive Healthcare Channel Management and Fortune 50 Expertise |
28-Aug-2002 |
| Quidel Meets Consensus Pre-Tax EPS on Record Second Quarter Revenues |
31-Jul-2002 |
| Quidel Introduces New Urinalysis Diagnostic Product, The UrinQuick(TM) Urine Chemistry Analyzer |
30-Jul-2002 |
| Quidel Launches Tests for Infectious Vaginitis, QuickVue(R) Advance pH and Amines and QuickVue(R) Advance G. Vaginalis Tests |
29-Jul-2002 |
| Quidel Joins Russell 3000(R) Index |
11-Jul-2002 |
| Quidel Second Quarter Conference Call Alert |
10-Jul-2002 |
| Quidel Corporation Amends Shareholder Rights Agreement to Permit Kopp Investment Advisors to Increase Ownership Position to 20% |
13-May-2002 |
| Quidel Announces Appointment of New Position for Vice President, Regulatory/Clinical and Quality Systems |
9-May-2002 |
| Quidel Corporation Recognized As 2002 Allegiance Healthcare 'SP Partner of the Year' |
7-May-2002 |
| Quidel Reports First Quarter Pre-Tax EPS of $0.09 on Total Revenues of $21.2M |
30-Apr-2002 |
| Quidel *First Quarter Conference Call Alert* |
11-Apr-2002 |
| Quidel Appoints Ernst & Young as Independent Public Accountants |
11-Apr-2002 |
| Quidel to Present at SG Cowen 22nd Annual Health Care Conference, March 12, 2002 |
7-Mar-2002 |
| Quidel Reports Record Fourth Quarter Pre-Tax EPS of $0.11 |
12-Feb-2002 |
| Quidel *Fourth Quarter Conference Call Alert |
23-Jan-2002 |
| Quidel *Fourth Quarter Conference Call Alert* |
23-Jan-2002 |
| Quidel's QuickVue(R) Influenza Test Receives Specific Reimbursement Code Just in Time for Flu Season |
14-Jan-2002 |
| Nation's Largest Osteoporosis Study Finds High Incidence of Undetected Cases |
19-Dec-2001 |
| Quidel's Metra(TM) DPD Osteoporosis Test Gains Mandatory National Medicare Coverage |
27-Nov-2001 |
| Quidel Corporation -Nasdaq: QDEL- Posts Information On the Web to Educate the Public About Influenza Testing and Pathogens That Can Cause Flu-like Symptoms |
19-Nov-2001 |
| Quidel Reports Record Third Quarter Net Sales |
1-Nov-2001 |
| Quidel *Third Quarter Conference Call Alert |
25-Oct-2001 |
| Quidel *Third Quarter Conference Call Alert* |
25-Oct-2001 |
| Quidel Corporation Offers Free Flu Tests to Public Health Agencies in Bioterrorism Planning |
17-Oct-2001 |
| Quidel's QuickVue(R) Influenza Test Launched in Japan |
10-Oct-2001 |
| Quidel To Present at UBS Warburg Global Life Sciences Conference, October 12, 2001 |
2-Oct-2001 |
| Quidel to Present at Wells Fargo Van Kasper Growth Stock Conference, Sept 5, 2001 |
27-Aug-2001 |
| Quidel Names Paul Landers as Chief Financial Officer |
20-Aug-2001 |
| Quidel Promotes S. Wayne Kay to CEO; Andre de Bruin Elected Chairman of the Board |
14-Aug-2001 |
| Quidel Receives Additional Patent Protection on LTF Technology; Patent Covers Use of Company Technology to Detect Vaginal Clue Cells |
2-Aug-2001 |
| Quidel Reports Second Quarter Results |
31-Jul-2001 |
| Quidel QuickVue(R) Dipstick Strep A Test Receives CLIA-Waived Status |
31-Jul-2001 |
| Quidel Corporation Wins Prestigious Supplier of the Year Award; Award Recognizes Best Sales Growth in the Primary Care Market |
24-Jul-2001 |
| Quidel *Conference Call Alert* |
24-Jul-2001 |
| Quidel Receives Significant Patent Protection on LTF Technology |
10-Jul-2001 |
| Quidel Corporation Announces Officer Resignation |
30-May-2001 |
| Quidel Corporation Receives FDA Clearance for New Strep A Test |
17-May-2001 |
| Quidel Corporation Announces First Quarter Results |
26-Apr-2001 |
| QUIDEL Corporation Confirms Its Achievement of Earnings Expectations |
26-Apr-2001 |
| Quidel Corporation Announces Conference Call Invitation |
19-Apr-2001 |
| Quidel Corporation Announces Issuance of Two U.S. Patents |
21-Mar-2001 |
| Quidel Announces European Patent Decision - German Court Upholds Company's Patent for Immunodiagnostic Device |
23-Feb-2001 |
| Quidel Reports Financial Results for the Quarter and Year Ended December 2000 |
15-Feb-2001 |
| Quidel Corporation (Nasdaq: QDEL) Conference Call Alert |
8-Feb-2001 |
| Quidel Launches New Biochemical Bone Marker Test |
1-Feb-2001 |
| Quidel Receives ISO Certification |
3-Jan-2001 |
| Quidel Announces Over-The-Counter Flu Test in European Countries |
19-Dec-2000 |
| Quidel Corporation Appoints S. Wayne Kay President, COO |
13-Dec-2000 |
| Quidel Introduces New and Improved Test for Peptic Ulcers |
9-Nov-2000 |
| Quidel Corporation to Acquire Litmus Concepts |
31-Oct-2000 |
| Quidel Corporation (Nasdaq: QDEL) Conference Call Alert |
31-Oct-2000 |
| Quidel Reports Third Quarter Earnings |
26-Oct-2000 |
| Quidel Rapid Flu Test Now Available for Widespread Use in the U.S. |
12-Oct-2000 |
| Quidel Comments on Earnings |
18-Sep-2000 |
| Quidel Announces U.S. Market Launch of Urinalysis Product |
16-Aug-2000 |
| Quidel Receives FDA Approval to Market Osteoporosis Device |
8-Aug-2000 |
| Quidel's Second Quarter Sales Increase 60% |
1-Aug-2000 |
| Quidel Comments on New Product Launches and Second Quarter Earnings |
27-Jun-2000 |
| Lin Haelewyn Promoted to Senior Vice President, And Appointed an Officer of Quidel Corporation |
9-Jun-2000 |
| Quidel Receives Approval to Market Influenza Test in Canada |
4-May-2000 |
| Quidel's First Quarter Sales Increase 66%, Pretax Profits More Than Double to $1.9 Million |
25-Apr-2000 |
| Quidel Reports Financial Results for the Three and Nine Months Ended December 31, 1999 - New Fiscal Year End |
17-Feb-2000 |
| Quidel Files to Register Common Stock Underlying Publicly Traded Warrants |
4-Feb-2000 |
| Quidel Comments on Earnings Outlook and Milestone Payment From Sumitomo |
1-Feb-2000 |
| Got The Flu? Are You Sure? |
19-Jan-2000 |
| Quidel Corporation Announces Sale/Leaseback of its San Diego Headquarters |
22-Dec-1999 |
| Quidel Corporation is Exclusive Licensee for Patent Granted for Peptide to be Used in Managing Osteoporosis |
14-Dec-1999 |
| Quidel Corporation Completes Acquisition of Urine Test Strip Business; Acquisition Expands Point-of-Care Diagnostic Products |
8-Dec-1999 |
| Quidel Begins Shipping Influenza Point-of-Care Diagnostic Test; 10-Minute QuickVue Influenza Test Available This Flu Season |
7-Dec-1999 |
| Quidel Reports Second Quarter Fiscal Year 2000 Financial Results |
3-Nov-1999 |
| Quidel Receives FDA Clearance for Influenza Point-of-Care Diagnostic Test |
27-Sep-1999 |
| Quidel Receives CLIA-Waived Status for H. pylori Diagnostic Test |
2-Sep-1999 |
| QUIDEL Receives FDA Clearance for Improved H. Pylori Diagnostic Test; Good News for Ulcer Sufferers |
18-Aug-1999 |
| Quidel Corporation Names New Board Member |
16-Aug-1999 |
| Quidel Reports First Quarter Fiscal Year 2000 Financial Results |
22-Jul-1999 |
| QUIDEL Corporation Signs Agreement to Acquire Metra Biosystems, Inc. in All Cash Transaction |
7-Jun-1999 |
| Quidel Reports Fourth Quarter and Fiscal 1999 Financial Results |
17-May-1999 |
| Quidel Seeks FDA Clearance For Point-Of-Care Influenza Diagnostic |
13-May-1999 |
| QUIDEL Joins Merck-Medco in Peptic Ulcer Disease Pilot Program |
12-May-1999 |
| Quidel Corporation Completes Acquisition of Metra Biosystems; Quidel Expands Product Line Into Osteoporosis Diagnostics |
11-Apr-1999 |
 |
